Hemotune
Hemotune was founded in 2017, is headquartered in Schlieren, Switzerland, lists 11–50 employees, and has 2 recorded funding rounds.
- Headquarters
- Schlieren, Zurich
- Employees
- 11–50
- Founded
- 2017
- Website
- hemotune.com
- Last Round
- Series BMar 2024
- Rounds
- 2
Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.
About
Hemotune is a Biotech company based in Schlieren, Switzerland, founded in 2017. It lists 11–50 employees. Its most recent funding was a Series B round in Mar 2024. Investors include OCCIDENT.
Funding History
Mar 2024
Sign up to see all 2 events
Funding: Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hemotune"><img src="https://indexed.vc/api/badge/company/hemotune" alt="Hemotune on Indexed.vc" width="260" height="76" /></a>